Zhiqiang Qin

High Impact

Associate Professor

UAMS

Also affiliated: Qingdao University (2017–2018); Zhejiang Sci-Tech University (2023); National Institute for Parasitic Diseases (2014); Medical University of South Carolina (2010–2011); Chinese Center For Disease Control and Prevention (2014); MUSC Hollings Cancer Center (2010); Nanjing Maternity and Child Health Care Hospital (2020); Ministry of Education (2012); The People's Hospital of Guangxi Zhuang Autonomous Region (2021–2025); Qingdao Municipal Hospital (2018); Jiangsu Cancer Hospital (2016); Institute of Forensic Science (2021–2023); Jiangsu Province Hospital (2016–2021); Nanjing Jiangning Hospital (2019); Zhejiang University (2013); Henan Medical University (2013); Nanjing Medical University (2012–2023)

Faculty Researcher

Pathology, College of Medicine

25 h-index 84 pubs 1,866 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group UAMS TRI Profile

OverviewAI-generated summary

Zhiqiang Qin's research investigates the molecular mechanisms underlying disease progression, with a particular focus on cancer and oxidative stress. He has published work examining the role of microRNAs and signaling pathways, such as the Keap1/Nrf2 pathway, in disease development and response to injury. His studies include investigating the NLRP3 inflammasome's involvement in the malignant progression of prostate cancer and the function of USP15 in testicular oxidative stress injury. Qin also applies computational methods to biological and forensic problems, including the use of deep learning for sex estimation from skeletal remains and the development of algorithms for inferring drowning site locations from diatom populations.

His work contributes to understanding disease mechanisms and exploring potential therapeutic targets. Qin's research group leads investigations into these areas, with scholarship metrics including an h-index of 24, 85 total publications, and 1,830 total citations. He has collaborated with researchers at the University of Arkansas for Medical Sciences, including Steven R. Post, Lu Dai, Jungang Chen, and Jiaojiao Fan.

Metrics

h-index: 25
Publications: 84
Citations: 1,866

Selected Publications

Targeting BRD2 and BRD4 inhibit the growth of KSHV-infected immortalized endothelial cells through suppression of LANA translation (2026)

PLoS Pathogens DOI OpenAlex
KSHV and Human Diseases: Beyond KS, PEL and MCD (2026)

Microorganisms DOI OpenAlex
Abstract 2987: Role of EIF4G1 network in non-small cell lung cancers (NSCLC) pathogenesis and development of targeted therapy (2025)

Cancer Research DOI OpenAlex
Infection of human induced pluripotent stem cells by an oncogenic herpesvirus (2025)

Frontiers in Cellular and Infection Microbiology DOI OpenAlex
Abstract 4384: Role of EIF4G1 in non-small cell lung cancer pathogenesis and targeted therapy (2019)

Molecular and Cellular Biology / Genetics DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

As listed on this researcher's institutional profile.

Seeds of Science Pilot award UAMS Internal Research Awards Principal Investigator
Development of O'PROTACs-based Novel EIF4G1 Degraders for Treatment of Non-small Cell Lung Cancer US Department of Defense Principal Investigator
Defining mechanisms of KSHV pathogenesis using MHV68-KSHV chimeric viruses NIH Co-Investigator
Periodontal bacteria enhance oral KSHV pathogenesis and Kaposi's Sarcoma development in HIV + patients - Continuation NIH/Nat. Cancer Institute Principal Investigator